Back to Search
LOUISE PYLE, MD, PHD
MD, PHD
Pediatrics Physician
NPI: 1699060277Individual
Specialties, Licenses & Credentials
Clinical Genetics (M.D.) Physician
Medical Genetics — Clinical Genetics (M.D.)
Code: 207SG0201X
MT200365(PA)
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
MT200365(PA)
Research & Publications (11)
Modifying middle school physical education: piloting strategies to increase physical activity.
PMID 19556623·Pediatr Exerc Sci·2009
3-trial
Sunitinib is superior to interferon alpha with respect to quality of life for patients with renal cell carcinoma.
PMID 19096396·Nat Clin Pract Oncol·2009
8-other
Randomized phase II study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinoma.
PMID 16484699·J Clin Oncol·2006
3-trial
A phase I pharmacokinetic and pharmacodynamic study of BGC9331 and carboplatin in relapsed gynaecological malignancies.
PMID 16222320·Br J Cancer·2005
3-trial
Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma.
PMID 15505625·Br J Cancer·2004
3-trial
A phase I dose-finding study of a combination of pegylated liposomal doxorubicin (Doxil), carboplatin and paclitaxel in ovarian cancer.
PMID 11986767·Br J Cancer·2002
3-trial
The treatment of advanced renal cell cancer with high-dose oral thalidomide.
PMID 11592764·Br J Cancer·2001
3-trial
Characterization of the maturation of human pro-apolipoprotein A-I in an in vitro model.
PMID 11258924·Biochemistry·2001
8-other
Deletion of the propeptide of apolipoprotein A-I reduces protein expression but stimulates effective conversion of prebeta-high density lipoprotein to alpha-high density lipoprotein.
PMID 11060357·J Lipid Res·2000
7-preclinical
A minimal ankyrin promoter linked to a human gamma-globin gene demonstrates erythroid specific copy number dependent expression with minimal position or enhancer dependence in transgenic mice.
PMID 10878017·J Biol Chem·2000
7-preclinical
Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer.
PMID 10732751·Br J Cancer·2000
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 34TH & CIVIC CENTER BOULEVARD, 9NW55, CHOP-PEDIATRIC RESIDENCY PROGRAM
PHILADELPHIA, PA 19104 - Phone
- (215) 590-1220
Quick Facts
- NPI
- 1699060277
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 11
Are you this provider?
Claim Your Profile